Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients.
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis.
The potential teratogenic effects of interferon beta-1a (IFNβ-1a) and interferon beta-1b (IFNβ-1b) on in vitro embryonic development.
Genzyme submits applications to FDA and EMA for approval of LEMTRADA™ (alemtuzumab) for multiple sclerosis
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial.
Rituximab in paediatric onset multiple sclerosis: a case series.
Receptos reports third quarter 2013 financial results
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
Impact of sleep disorder treatment on fatigue in multiple sclerosis.
US court permits generic version of Teva MS drug a year sooner
Fourth PML Case With Tecfidera in MS Calls for Vigilance
Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study
Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis.
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
URMC rheumatologist presents data showing drug’s potential to ease arthritis symptoms
Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis.
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
The Relative Importance of Baseline Pain, Fatigue, Sleep and Physical Activity: Predicting Change in Depression in Adults with Multiple Sclerosis.
The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis.
Oxidative modification of serum proteins in multiple sclerosis.

Pages